Enova International, Inc. (ENVA) stock analysis
Close on Nov 12, 2026Market cap $4.09BP/E 11.5Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed10 of 30 checks passed
Enova International passes 10 of the 30 checks behind our score; 10 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 2/6
- Growth
- 5/6
- Past performance
- 3/6
- Financial health
- 0/6
- Dividend
- 0/6
What stands out
Margin of safety over 20%
The price is 27.8% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $171.16 is below our fair value estimate of $236.94.
Return on equity over 15%
Return on equity was 26.8% over the last twelve months and averaged 19.9% over five years.
Return on capital over 10%
Return on invested capital was 50.4%, above the 10% that usually covers the cost of capital.
What to watch
Earnings shrank over 5 years
Net income shrank 4.0% a year on average over the last five fiscal years.
Interest not well covered
Operating income covers interest expense 2.3 times; we look for at least 5.
Elevated bankruptcy risk
The Altman Z-score is 1.68; above 3 is the safe zone and below 1.8 the distress zone.
P/E above its 5-year median
Enova International's P/E of 11.8 is above its own 5-year median of 11.1.
Valuation2/6
P/E above its 5-year median
Enova International's P/E of 11.8 is above its own 5-year median of 11.1.
P/E above the industry
Enova International's P/E of 11.8 is above the Personal Credit Institutions median of 8.8.
EV/EBITDA above its 5-year median
Enova International's EV/EBITDA of 4.5 is above its 5-year median of 3.7.
P/B above the industry
Enova International's price-to-book of 2.67 is above the Personal Credit Institutions median of 1.50.
Trading below fair value
The share price of $171.16 is below our fair value estimate of $236.94.
Margin of safety over 20%
The price is 27.8% below fair value, more than the 20% cushion we look for.
Growth5/6
Revenue growing 10%+ a year
Revenue grew 22.0% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 23.0% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 30.5% over the last twelve months, against a 5-year average of -4.0% a year.
Growing faster than the industry
Revenue grew 20.1% over the last twelve months; the Personal Credit Institutions median is 8.8%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin improving
Gross margin was 60.6% over the last twelve months, against 57.2% a year earlier.
Past performance3/6
Return on equity over 15%
Return on equity was 26.8% over the last twelve months and averaged 19.9% over five years.
Return on capital over 10%
Return on invested capital was 50.4%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
Enova International's return on equity of 26.8% is above the Personal Credit Institutions median of 22.7%.
Earnings shrank over 5 years
Net income shrank 4.0% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 10.5% over the last twelve months, against a 5-year average of 11.8%.
Net margin below the industry
Enova International's net margin of 10.5% is below the Personal Credit Institutions median of 13.4%.
Financial health0/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest not well covered
Operating income covers interest expense 2.3 times; we look for at least 5.
Short-term liquidity
The balance sheet is not split into current and non-current items.
Elevated bankruptcy risk
The Altman Z-score is 1.68; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Enova International has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$236.94
The share price is 28% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 9.9× | 11.1× | 8.8× | $144.18 | 44% |
| EV/EBITDA | 5.9× | 3.7× | 8.2× | $226.09 | 39% |
| Earnings power | 11.8% cost of equity | – | – | $509.60 | 17% |
| Fair value | $236.94 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 11.1
- Personal Credit Institutions median 8.8
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $59.66M
- Value traded per 1% price move
- $33.53M
Downside
High risk
- Typical loss in a bad month
- 29.4%
- Volatility (annualized)
- 46%
- Sharpe ratio, 1 year
- 0.66
- Beta to the S&P 500 (5Y)
- 1.38
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +18.6% | +22.0% | +23.8% | +17.1% | |
| Gross profit | +19.7% | +17.9% | +21.7% | +15.4% | |
| Operating income | +26.5% | +24.4% | +15.6% | +19.5% | |
| Net income | +47.2% | +14.1% | -4.0% | +21.5% | |
| EPS, diluted | +55.0% | +23.0% | -0.3% | +24.1% | |
| Free cash flow | +18.5% | +27.7% | +20.0% | +21.6% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 15.5% | 58.4% | 24.3% | |
| Return on assets | 3.8% | 20.5% | 5.3% | |
| Interest coverage | – | 4.1× | 2.2× | |
| Capex to revenue | 1.9% | 2.7% | 1.5% | |
| Diluted shares | 33M | 32M | 27M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Enova International generated $5.89B from operations and spent $1.13B on capital expenditure, dividends and share buybacks. 19% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 9.8% | 0.54× | 4.63× | 24.3% |
| FY2024 | 7.9% | 0.54× | 4.04× | 17.2% |
| FY2023 | 8.3% | 0.51× | 3.45× | 14.4% |
| FY2022 | 11.9% | 0.53× | 2.87× | 18.2% |
| FY2021 | 21.2% | 0.50× | 2.42× | 25.5% |
| FY2020 | 34.9% | 0.59× | 2.85× | 58.4% |
| FY2019 | 3.1% | 0.81× | 4.02× | 10.1% |
| FY2018 | 7.2% | 0.78× | 3.96× | 22.3% |
| FY2017 | 4.0% | 0.68× | 4.08× | 11.2% |
| FY2016 | 4.6% | 0.82× | 4.06× | 15.5% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$308.39M
- Cash generatingOperating cash flow above zero$1.82B
- Return on assets improvedROA up on the prior year4.6% → 5.9%
- Earnings backed by cashOperating cash flow above net income$1.82B vs $308.39M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise28M → 27M
- Gross margin improvedGross margin up on the prior year57.55% → 58.07%
- More efficientAsset turnover rose0.58 → 0.60
See a number that looks wrong?